Four Japan Firms Make Major Moves Into iPS Stem Cell Businesses
This article was originally published in PharmAsia News
Executive Summary
Nikon, Nippi, Shimadzu and Taiyo Nippon Sanso are among Japanese companies focusing on the field of induced pluripotent stem cells to serve the increasing demand for new medical treatments.